Global Antibiotic R&D Partnership (GARDP)
Astrid Pentz-Murr is a seasoned professional in the field of scientific affairs with extensive experience in antibiotic research and healthcare communication. Currently serving as the Scientific Affairs Senior Manager at the Global Antibiotic R&D Partnership (GARDP) since January 2018, Astrid has previously held several roles within the organization, including Community Manager and Senior Officer for Scientific Affairs. Prior to GARDP, Astrid worked as a Freelance Writer and in various roles at Weber Shandwick, focusing on healthcare public relations. Astrid gained foundational research experience as a PhD student at the Friedrich Miescher Institute for Biomedical Research and has a solid academic background with a Master of Science in Molecular Biology from the University of Vienna and a Bachelor of Science in Biomedical Engineering from Fachhochschule Technikum Wien.
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org